These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 15196967)
1. Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells. Hasegawa T; Matsuzaki M; Takeda A; Kikuchi A; Akita H; Perry G; Smith MA; Itoyama Y Brain Res; 2004 Jul; 1013(1):51-9. PubMed ID: 15196967 [TBL] [Abstract][Full Text] [Related]
2. Histochemical features of stress-induced aggregates in alpha-synuclein overexpressing cells. Matsuzaki M; Hasegawa T; Takeda A; Kikuchi A; Furukawa K; Kato Y; Itoyama Y Brain Res; 2004 Apr; 1004(1-2):83-90. PubMed ID: 15033422 [TBL] [Abstract][Full Text] [Related]
3. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine. Moussa CE; Wersinger C; Tomita Y; Sidhu A Biochemistry; 2004 May; 43(18):5539-50. PubMed ID: 15122920 [TBL] [Abstract][Full Text] [Related]
4. Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage. Lev N; Melamed E; Offen D Neurosci Lett; 2006 May; 399(1-2):27-32. PubMed ID: 16584840 [TBL] [Abstract][Full Text] [Related]
5. Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells. Gómez-Santos C; Ferrer I; Santidrián AF; Barrachina M; Gil J; Ambrosio S J Neurosci Res; 2003 Aug; 73(3):341-50. PubMed ID: 12868068 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of alpha-synuclein decreased viability and enhanced sensitivity to prostaglandin E(2), hydrogen peroxide, and a nitric oxide donor in differentiated neuroblastoma cells. Prasad JE; Kumar B; Andreatta C; Nahreini P; Hanson AJ; Yan XD; Prasad KN J Neurosci Res; 2004 May; 76(3):415-22. PubMed ID: 15079871 [TBL] [Abstract][Full Text] [Related]
7. Induction of C/EBP beta and GADD153 expression by dopamine in human neuroblastoma cells. Relationship with alpha-synuclein increase and cell damage. Gómez-Santos C; Barrachina M; Giménez-Xavier P; Dalfó E; Ferrer I; Ambrosio S Brain Res Bull; 2005 Feb; 65(1):87-95. PubMed ID: 15680548 [TBL] [Abstract][Full Text] [Related]
8. Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro. McLean PJ; Klucken J; Shin Y; Hyman BT Biochem Biophys Res Commun; 2004 Aug; 321(3):665-9. PubMed ID: 15358157 [TBL] [Abstract][Full Text] [Related]
9. Abnormal migration of human wild-type alpha-synuclein upon gel electrophoresis. Moussa CE; Wersinger C; Rusnak M; Tomita Y; Sidhu A Neurosci Lett; 2004 Nov; 371(2-3):239-43. PubMed ID: 15519765 [TBL] [Abstract][Full Text] [Related]
10. A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein. Zhou C; Emadi S; Sierks MR; Messer A Mol Ther; 2004 Dec; 10(6):1023-31. PubMed ID: 15564134 [TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation. Shaikh S; Nicholson LF J Neurosci Res; 2008 Jul; 86(9):2071-82. PubMed ID: 18335520 [TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein: normal function and role in neurodegenerative diseases. Norris EH; Giasson BI; Lee VM Curr Top Dev Biol; 2004; 60():17-54. PubMed ID: 15094295 [TBL] [Abstract][Full Text] [Related]
13. alpha-Synuclein overexpression during manganese-induced apoptosis in SH-SY5Y neuroblastoma cells. Li Y; Sun L; Cai T; Zhang Y; Lv S; Wang Y; Ye L Brain Res Bull; 2010 Mar; 81(4-5):428-33. PubMed ID: 19932157 [TBL] [Abstract][Full Text] [Related]
14. Synucleins and their relationship to Parkinson's disease. von Bohlen Und Halbach O Cell Tissue Res; 2004 Oct; 318(1):163-74. PubMed ID: 15503152 [TBL] [Abstract][Full Text] [Related]
15. Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein. Lee HJ; Khoshaghideh F; Lee S; Lee SJ Eur J Neurosci; 2006 Dec; 24(11):3153-62. PubMed ID: 17156376 [TBL] [Abstract][Full Text] [Related]
16. Degradation of wild-type alpha-synuclein by a molecular chaperone leads to reduced aggregate formation. Kong B; Chae Y; Lee K Cell Biochem Funct; 2005; 23(2):125-32. PubMed ID: 15624119 [TBL] [Abstract][Full Text] [Related]
17. Impairment of redox state and dopamine level induced by alpha-synuclein aggregation and the prevention effect of hsp70. Yu F; Xu H; Zhuo M; Sun L; Dong A; Liu X Biochem Biophys Res Commun; 2005 May; 331(1):278-84. PubMed ID: 15845390 [TBL] [Abstract][Full Text] [Related]
18. Role of alpha-synuclein carboxy-terminus on fibril formation in vitro. Murray IV; Giasson BI; Quinn SM; Koppaka V; Axelsen PH; Ischiropoulos H; Trojanowski JQ; Lee VM Biochemistry; 2003 Jul; 42(28):8530-40. PubMed ID: 12859200 [TBL] [Abstract][Full Text] [Related]
19. Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies. Iwata A; Maruyama M; Akagi T; Hashikawa T; Kanazawa I; Tsuji S; Nukina N Hum Mol Genet; 2003 Oct; 12(20):2625-35. PubMed ID: 12928483 [TBL] [Abstract][Full Text] [Related]
20. Rotenone induces aggregation of gamma-tubulin protein and subsequent disorganization of the centrosome: relevance to formation of inclusion bodies and neurodegeneration. Diaz-Corrales FJ; Asanuma M; Miyazaki I; Miyoshi K; Ogawa N Neuroscience; 2005; 133(1):117-35. PubMed ID: 15893636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]